An Educational Resource to Aid in Understanding AntibioticsDecember 16th 2021
The website, LearnAntibiotics.com, is a supplemental tool offering guides, practice exams, and other resources to help students, residents, or practicing professionals with infectious diseases pharmacotherapy.
IDSA Releases New Guidelines for Treating Antimicrobial-Resistant InfectionsNovember 22nd 2021
The Infectious Diseases Society of America (IDSA) released new expert-informed guidelines for treating antimicrobial-resistant AmpC β-lactamase-producing Enterobacterales (AmpC-E), carbapenem-resistant Acinetobacter baumannii (CRAB), and Stenotrophomonas maltophilia infections.
National Academies Report: New Antimicrobials Must Overcome Market Barriers Before Combating Resistant StrainsNovember 22nd 2021
The report on antimicrobial resistance finds new therapeutics are "essential to future of clinical medicine" but may not be viable in present market.
Antibiotic Prescribing Practices During COVID-19November 21st 2021
As providers were challenged to care for patients with severe COVID-19 In the first year of the pandemic, antibiotic usage increased. Listen to clinicians talk about this specific challenge and how prescribing practices evolved over time.
Antibiotics: From Accidental Discovery to Cornerstone of MedicineNovember 19th 2021
From its origins as a serendipitous discovery to being successfully prescribed for nearly a century, antibiotics remain a foundation of medicine. However it has major ongoing challenges including the rise of superbugs and the development of antimicrobial resistance (AMR). There are some prospective strategies to combat AMR on the horizon.
Largest Decrease in Antibiotic Use in 20 Years Coincides with COVID-19 PandemicNovember 18th 2021
The European Center for Diseases Prevention and Control published data today showing the greatest decrease in antibiotic consumption in 2 decades coincided with the COVID-19 pandemic.
National Academies Report: Timely Diagnostics can Facilitate New Antimicrobials, Better StewardshipNovember 18th 2021
In the second installment discussing this report, the authors point out that the approval of new diagnostics can help facilitate better stewardship.
Venatorx Pharmaceuticals is Developing Therapeutic Improvements to Fight Gram Negative Bacterial and Viral InfectionsNovember 17th 2021
CEO Christopher Burns spoke about their investigational therapy pipeline, the long view perspective for the company, and how the federal government’s use of the nomenclature innovation might actually hinder incremental improvements in antibiotic development.